PT - JOURNAL ARTICLE AU - Rodrigo Alonso Moralejo AU - Salvador de la Torre Carazo AU - Trinidad Diaz Cambriles AU - Jesus Muñoz Mendez AU - Maria Josefa Diaz de Atauri AU - Angel Lopez Encuentra TI - cPAP compliance and survival in elderly and sleep apnoea patients DP - 2011 Sep 01 TA - European Respiratory Journal PG - 3244 VI - 38 IP - Suppl 55 4099 - http://erj.ersjournals.com/content/38/Suppl_55/3244.short 4100 - http://erj.ersjournals.com/content/38/Suppl_55/3244.full SO - Eur Respir J2011 Sep 01; 38 AB - Introduction: Sleep apnea-hypopnea syndrome (SAHS) prevalence increases with age, but very few data are available on this population.Aim: To describe the clinical features, survival and tolerance to cPAP treatment of aged patients.Methods: Observational, concurrently study performed during ten years including patients with SAHS evaluated in our Sleep Disorders Unit (SDU) at the age of 80 or older. Failure of treatment was defined when cPAP use was below 3.5 hours per day. Kaplan Meier and Log rank tests were performed for the survival analysis.Results: 1.8% (144/7989) of patients were at least 80 years old when were studied in our SDU. There were 72 women (50%). The patients characteristics expressed by mean and standard deviation were, age: 82 (1.7), body mass index: 33 (4.3) Epworth test: 12.5 (5.3), neck circumference 41.2 (9). The 93% (135/144) of the patients were diagnosed of SAHS. 57% (83/144) of the patients started treatment with cPAP. 28/83 (34%) of them used it less than 3.5 hours. The survival analysis results are listed in the table beneath:View this table:Use of cPAPConclusion: Although the percentage of aged patients is low compared with the whole population, those who fulfil correct treatment with cPAP seem to have a longer survival in 10 years.